The effects of tubal sterilization on menopausal age in a cohort of postmenopausal women.

Year 2021, Volume: 38 Issue: 4, 589 - 593, 09.10.2021

Utku Akgör , Samet Kırat Celalettin Tok

Abstract

Objectives: To evaluate whether tubal sterilization (TS) has an adverse effect on menopausal age in a cohort of postmenopausal women.
Study design: The medical records on TS were gathered from 1,228 postmenopausal women in menopause clinic at a tertiary hospital.
Results: The age at menarche, the parity, smoking and secondhand smoking status and mother’s age at menopause did not show any significant difference between the groups. Likewise, marital status, educational and yearly income levels were comparable (P > 0.01). Although the mean BMI (P = 0.06) and the rate of oral contraceptive use (P = 0.09) were tended to be higher in non-TS women than in TS group, the difference did not reach statistical significance. The ever use of intrauterine device rate was significantly lower in TS group than in non-TS group (P <0.001). The TS women, in comparison with the non-TS women had undergone earlier natural menopause (P <0.001). The age at menopause had an inverse correlation with TS, and positive correlation with mother’s age at menopause in univariate analyses. However, there was marginally significant correlation between secondhand smoking and age at menopause. Linear stepwise regression analyses revealed that TS and mother’s age at menopause were independent predictors of age at menopause (P < 0.05).
Conclusions: We found an earlier age at menopause in women with TS in this study. In this regard, this is the first report about the age at menopause in women with TS, as far as we know.

Keywords

menopausal age, tubal sterilization, menopause.

References

• Referans1 'ACOG Practice Bulletin No. 208 Summary: Benefits and Risks of Sterilization'. 2019. Obstet Gynecol, 133: 592-94.
• Referans2 Bulent Tiras, M., V. Noyan, H. Ozdemir, H. Guner, A. Yildiz, and M. Yildirim. 2001. 'The changes in ovarian hormone levels and ovarian artery blood flow rate after laparoscopic tubal sterilization', Eur J Obstet Gynecol Reprod Biol, 99: 219-21.
• Referans3 Carmona, F., P. Cristobal, R. Casamitjana, and J. Balasch. 2003. 'Effect of tubal sterilization on ovarian follicular reserve and function', Am J Obstet Gynecol, 189: 447-52.
• Referans4 Cattanach, J. 1985. 'Oestrogen deficiency after tubal ligation', Lancet (London, England), 1: 847-49.
• Referans5 Cattanach, J. F., and B. J. Milne. 1988. 'Post-tubal sterilization problems correlated with ovarian steroidogenesis', Contraception, 38: 541-50.
• Referans6 Dede, F. S., B. Dilbaz, O. Akyuz, E. Caliskan, V. Kurtaran, and S. Dilbaz. 2006. 'Changes in menstrual pattern and ovarian function following bipolar electrocauterization of the fallopian tubes for voluntary surgical contraception', Contraception, 73: 88-91.
• Referans7 Ercan, C. M., M. Sakinci, H. Coksuer, U. Keskin, S. Tapan, and A. Ergun. 2013. 'Ovarian reserve testing before and after laparoscopic tubal bipolar electrodesiccation and transection', Eur J Obstet Gynecol Reprod Biol, 166: 56-60.
• Referans8 Fagundes, M. L., M. C. Mendes, M. C. Patta, R. Rodrigues, A. T. Berezowski, M. D. de Moura, and M. E. Yazlle. 2005. 'Hormonal assessment of women submitted to tubal ligation', Contraception, 71: 309-14.
• Referans9 Ganer Herman, H., O. Gluck, R. Keidar, R. Kerner, M. Kovo, D. Levran, J. Bar, and R. Sagiv. 2017. 'Ovarian reserve following cesarean section with salpingectomy vs tubal ligation: a randomized trial', Am J Obstet Gynecol, 217: 472.e1-72.e6.
• Referans10 Gentile, G. P., S. C. Kaufman, and D. W. Helbig. 1998. 'Is there any evidence for a post-tubal sterilization syndrome?', Fertil Steril, 69: 179-86.
• Referans11 Kelekci, S., B. Yilmaz, L. Yasar, K. Savan, S. Sonmez, and C. Kart. 2005. 'Ovarian reserve and ovarian stromal blood supply after tubal ligation by the Pomeroy technique: comparison with controls', Gynecol Endocrinol, 20: 279-83.
• Referans12 Nelson, D. B., M. D. Sammel, E. W. Freeman, C. R. Gracia, L. Liu, and E. Langan. 2005. 'Tubal ligation does not affect hormonal changes during the early menopausal transition', Contraception, 71: 104-10.
• Referans13 Nichols, H. B., D. D. Baird, L. A. DeRoo, G. E. Kissling, and D. P. Sandler. 2013. 'Tubal ligation in relation to menopausal symptoms and breast cancer risk', Br J Cancer, 109: 1291-5.
• Referans14 Nyberg, F., A. Agudo, P. Boffetta, C. Fortes, C. A. Gonzalez, and G. Pershagen. 1998. 'A European validation study of smoking and environmental tobacco smoke exposure in nonsmoking lung cancer cases and controls', Cancer Causes Control, 9: 173-82.
• Referans15 Okeke, T., U. Anyaehie, and C. Ezenyeaku. 2013. 'Premature menopause', Ann Med Health Sci Res, 3: 90-5.
• Referans16 Ozyer, S., O. Moraloglu, C. Gulerman, Y. Engin-Ustun, O. Uzunlar, R. Karayalcin, and M. Ugur. 2012. 'Tubal sterilization during cesarean section or as an elective procedure? Effect on the ovarian reserve', Contraception, 86: 488-93.
• Referans17 Peterson, H. B., G. Jeng, S. G. Folger, S. A. Hillis, P. A. Marchbanks, and L. S. Wilcox. 2000. 'The risk of menstrual abnormalities after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group', N Engl J Med, 343: 1681-7.
• Referans18 Revel, A., Y. Abramov, S. Yagel, and M. Nadjari. 2004. 'Utero-ovarian morphology and blood flow after tubal ligation by the Pomeroy technique', Contraception, 69: 151-6.
• Referans19 s, W. H. O. Scientific Group on Research on the Menopause in the, and Organization World Health. 1996. "Research on the menopause in the 1990s : report of a WHO scientific group." In. Geneva: World Health Organization.
• Referans20 Silva, A. L., Cd Re, C. Dietrich, I. P. Fuhrmeister, A. Pimentel, and H. V. Corleta. 2013. 'Impact of tubal ligation on ovarian reserve as measured by anti-Mullerian hormone levels: a prospective cohort study', Contraception, 88: 700-5.
• Referans21 Silva, A. L., Cd Ré, C. Dietrich, I. P. Fuhrmeister, A. Pimentel, and H. V. Corleta. 2013. 'Impact of tubal ligation on ovarian reserve as measured by anti-Müllerian hormone levels: a prospective cohort study', Contraception, 88: 700-5.
• Referans22 Souza, A. Z., A. M. Fonseca, V. M. Izzo, R. M. Clauzet, and C. A. Salvatore. 1986. 'Ovarian histology and function after total abdominal hysterectomy', Obstet Gynecol, 68: 847-9.
• Referans23 Sumiala, S., J. Pirhonen, J. Tuominen, and J. Maenpaa. 1995. 'Increased uterine and ovarian vascular resistance following Filshie clip sterilization: preliminary findings obtained with color Doppler ultrasonography', J Clin Ultrasound, 23: 511-6.
• Referans24 Visvanathan, N., and G. Wyshak. 2000. 'Tubal ligation, menstrual changes, and menopausal symptoms', J Womens Health Gend Based Med, 9: 521-7.
• Referans25 Wilcox, L. S., B. Martinez-Schnell, H. B. Peterson, J. H. Ware, and J. M. Hughes. 1992. 'Menstrual function after tubal sterilization', Am J Epidemiol, 135: 1368-81.
• Referans26 Williams, E. L., H. E. Jones, and R. E. Merrill. 1951. 'The subsequent course of patients sterilized by tubal ligation; a consideration of hysterectomy for sterilization', Am J Obstet Gynecol, 61: 423-6.
• Referans27 Wyshak, G. 2004. 'Menopausal symptoms and psychological distress in women with and without tubal sterilization', Psychosomatics, 45: 403-13. ———. 2005. 'Tubal ligation and the risk of vertebral fractures', Osteoporos Int, 16: 651-8.